WW - WeightWatchers Enhances Enterprise Offering with Full-Spectrum Access to Weight Health | Benzinga
NEW YORK, Oct. 06, 2023 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ:WW), ("WeightWatchers," "WW," or the "Company") announced today that WeightWatchers for Business has fully integrated WW's science-proven behavioral program with its virtual obesity clinic and medication management. The Company now offers a full spectrum weight health platform designed for employers and health plans, that delivers individualized member pathways based on true clinical need.
As prevalence of chronic diseases increases, organizations are challenged with higher costs, with experts predicting a 2-10% increase in insurance premiums in 20241. Among the many contributing factors are the increased utilization and cost of GLP-1 medications indicated for weight loss and diabetes. To help organizations navigate this new landscape, WeightWatchers for Business is building on its 30+ years of science-backed expertise in the employer-sponsored healthcare space with a complete cost management and utilization strategy that includes preventing progression and facilitating remission of weight-related conditions, as well as managing weight before, during, and after pharmacotherapy. WeightWatchers for Business utilizes evidence-based clinical pathways and step therapy with proprietary de-escalation protocols designed to drive clinically significant outcomes while controlling cost.
"Health plans, PBMs, and their clients are grappling with unprecedented demand for this new class of chronic weight management medications and the associated costs," stated Kevin O'Brien, Senior Vice President of Commercial Growth ...